Failure patterns after definitive radiotherapy with elective neck irradiation ≤ 40 Gy for head and neck cancer: a multi-institutional study
Journal of Radiation Research · 2026-10-31
DOI: 10.1093/jrr/rrag093 ↗Abstract
Abstract To evaluate the efficacy and patterns of failure after definitive radiotherapy (RT) using an elective nodal irradiation (ENI) dose of ≤40 Gy for head and neck cancer. We retrospectively analyzed 290 patients with stage I–IV oropharyngeal cancer (OPC), hypopharyngeal cancer (HPC), or laryngeal cancer (LYC) who underwent definitive RT with an ENI dose of ≤40 Gy at three institutions between 2008 and 2024. A total of 278 patients received 40 Gy of ENI, whereas ENI was omitted in 12 patients (ENI-omission). The study endpoints included patterns of failure, local control (LC), regional control (RC), progression-free survival (PFS) and overall survival (OS). With a median follow-up of 35 months among surviving patients, the 2-year LC, RC, PFS and OS rates were 79.8%, 91.2%, 63.1% and 79.8%, respectively. Regional recurrence within the ENI field occurred in only four patients (1.4%), including no patients in the ENI-omission group and four in the 40-Gy ENI group. Only one patient experienced an isolated ENI field recurrence. In the multivariable analysis, advanced N category, systemic therapy and prescribed dose were associated with OS. Advanced N category was also an independent predictor of both RC and PFS. Definitive RT using an ENI dose of ≤40 Gy achieved favorable oncologic outcomes with low incidence of regional recurrence within the ENI field. These findings support the feasibility of an ENI dose of ≤40 Gy while maintaining enough elective nodal control.
EUVIMED